AbbVie partners with Valkai to deploy AI across clinical development

• AbbVie entered a partnership with Valkai to deploy AI tools across targeted areas of clinical development.
• Collaboration aims to improve efficiency in clinical research, speed insight generation, reduce drug development timelines.
• Deal expands AbbVie’s use of AI across R&D as clinical data volumes and complexity increase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CG57210) on September 29, 2026, and is solely responsible for the information contained therein.